Minerva Neurosciences, Inc. (NERV) (CIK 0001598646) (NERV)
Activity window: Nov. 12, 2025 to Nov. 11, 2026
Export this company’s current score, component values, matched signals, and scoring date as a one-row CSV snapshot.
The total combines correspondence volume, AI sentiment, matched keywords and signals, and a weighted 8-K adjustment, capped at 10.0. This is the 365-day v1 snapshot. Computed: Nov. 11, 2026. Latest filing activity: Mar. 17, 2026. These dates describe different events.
| Date | Form | Sentiment | Urgency | Summary | Open |
|---|---|---|---|---|---|
| Mar. 17, 2026 | CORRESP | Neutral/Informational | Moderate | Minerva Neurosciences, Inc. has submitted a request to the SEC for the acceleration of their Registration Statement on Form S-3, seeking to have it become effective on March 19, 2… | Read Filing EDGAR |
| Mar. 16, 2026 | UPLOAD | Neutral/Informational | Low | The SEC correspondence dated March 16, 2026, informs Minerva Neurosciences, Inc. that their registration statement on Form S-3, filed on March 11, 2026, will not be reviewed by th… | Read Filing EDGAR |
| Jan. 2, 2026 | CORRESP | Neutral/Informational | Moderate | Minerva Neurosciences, Inc. has submitted a request to the SEC for the acceleration of their Registration Statement on Form S-3, seeking to have it declared effective by January 6… | Read Filing EDGAR |
| Dec. 31, 2025 | UPLOAD | Neutral/Informational | Low | The SEC has communicated to Minerva Neurosciences, Inc. that it will not review their registration statement filed on December 23, 2025. The letter emphasizes the company's respon… | Read Filing EDGAR |